Acute pulmonary hypertension after cardiopulmonary bypass in pig: The role of endogenous endothelin

European Journal of Cardio-thoracic Surgery

Volumn 15, Issue 3, 1999, Pages 346-352

  Carteaux, Jean Pierre ^a   Roux, Sébastien ^b   Siaghy, Medhi ^a   Schjöth, Bruno ^a   Dolofon, Patricia ^a   Bechamps, Yves ^a   Mertes, Paul Michel ^a   Villemot, Jean Pierre ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Acute pulmonary arterial hypertension; Bosentan; Cardiopulmonary bypass; Endothelin; Pig

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; THROMBOXANE A2;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CARDIOPULMONARY BYPASS; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; MEDIATOR RELEASE; MORBIDITY; NEWBORN; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL MORTALITY; SWINE; THROMBOCYTE ACTIVATION; VASODILATATION;

ACUTE DISEASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOPULMONARY BYPASS; ENDOTHELIN-1; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; SULFONAMIDES; SWINE;

EID: 0032956980     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(99)00017-2     Document Type: Article

References (19)

1. Hopkins R.A., Bull C., Haworth S.G., Leval M.R., Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardio-thorac Surg. 5:1991;628-634.
2. Wessel D.L., Adatia I., Giglia T.M., Thompson J.E., Kulic T.J. Use of inhaled nitric oxide and acethylcholine in the evaluation of pulmonary artery hypertension and endothelial function after cardiopulmonary bypass. Circulation. 88:1993;447-453.
3. Levin E.R. Endothelins. N Engl J Med. 6:1995;356-363.
4. Janakidevi K., Fisher M.A., Del Vecchio P.J., Tiruppathi C., Figge J., Malik A.B. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol. 6:1992;C1295-C1301.
5. Ishikawa S., Miyachi T., Sakai S., Ushinohama H., Sagawa K., Fusazaki N., Kado H., Sunagawa H., Honda S., Ueno H., Yamaguchi I., Sugishita Y., Goto K. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cardiovasc Surg. 1:1995;271-273.
6. Clozel M., Breu V., Burri K., Cassal J.M., Fischli W., Gray G.A., Hirth G., Löffler B.M., Muller M., Neidhart W. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 6448:1993;759-761.
7. Löffler B.M., Marie J.P. Radioimmunology determination of endothelin peptides in human plasma: a methodological approach. Endothelium. 4:1994;273-286.
8. Goldman A.P., Delius R.E., Deanfield J.E., Macrae D.J. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg. 60:1995;300-306.
9. Cacoub P., Dorent R., Maistre G., Nataf P., Carayon A., Piette C., Godeau P., Cabrol C., Gandjbakhch I. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol. 5:1993;448-450.
10. Lundbald R., Oddvar M., Fosse E. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 63:1997;1361-1367.
11. Tönz M., Mihaljevic T., von Segesser L.K., Shaw S., Lüscher T.F., Turina M. Postoperative hemodynamics depend on cardiopulmonary bypass temperature: the potential role of endothelin-1. Eur J Cardio-thorac Surg. 11:1997;157-161.
12. Chen SJ, Chen YF, Meng QC, Durand J, Dicarlov S, Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl Physiol 1995;79:2122-2131.
13. Okada M., Yamashita C., Okada M., Okada K. Endothelin receptor antagonists in a Beagle model of pulmonary hypertension: contribution to possible potential therapy? J. Am. Coll Cardiol. 5:1995;1213-1217.
14. Weitzberg E, Hemsen A, Rudehill A. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol 1996;118:617-626.
15. Kirshbom P.M., Tsui S.S.L., DiBernardo L.R., Meliones J.N., Schwinn D.A., Ungerleider R.M., Gaynor J.W. Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest. Surgery. 118:1995;440-445.
16. Reddy VM, Hendricks-Munoz KD, Rajasinghe HA, Petrossian E, Handley FL, Fineman JR. Post-cardiopulmonary bypass hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1. Circulation 1997;95:1054-1061.
17. Weitzberg E., Rudehill A., Modin A., Lundberg J.M. Porcine intrinsic pulmonary and systemic vascular tone is endothelin-dependent. Acta Physiol Scand. 4:1994;433-434.
18. Haynes W.G., Ferro C.J., O'Kane K.P.J., Somerville D., Lomax C.C., Webb D.J. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 10:1996;1860-1870.
19. Kiowski W., Sutsch G., Hunziker P.et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 8977:1995;732-736.